TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

127.60$ +2.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 5,141 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement INCY
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
42 90 135 157 194 219 95 41 14 7.8 28 34 3.9 9.3 170 94 297 355 511 754 1,106 1,536 1,882 2,159 2,667 2,986 3,395 3,696 4,241 5,141
-6.5 -11 -18 -25 -35 242 172 135 103 103 98 116 161 146 155 235 0.2 0.6 3.0 27 58 79 94 114 131 151 207 255 312 372
48 101 153 182 229 219 102 47 14 7.8 28 34 3.9 9.3 170 94 297 354 508 727 1,048 1,457 1,788 2,045 2,535 2,835 3,188 3,441 3,929 4,769
41 73 97 147 193 213 145 111 88 96 88 105 146 119 124 179 210 260 348 480 582 1,326 1,198 1,154 2,216 1,458 1,586 1,628 2,607 2,050
6.8 12 25 37 64 71 47 30 75 13 17 15 17 28 32 58 85 110 166 197 303 366 424 469 517 740 1,002 1,161 1,222 1,376
57 97 140 209 292 284 228 191 163 109 105 120 163 149 156 238 296 370 513 676 903 1,700 1,659 1,643 2,799 2,249 2,596 2,785 3,828 3,426
-8.9 3.6 12 -27 -63 -65 -133 -149 -149 -101 -77 -85 -159 -140 14 -143 1.1 -16 -4.8 51 145 -243 129 402 -264 586 592 655 101 1,343
0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.0 17 16 18 24 25 32 43 44 46 39 47 46 39 6.9 1.5 1.9 2.2 1.9 2.7 2.6 2.3 2.4
-6.6 7.4 5.9 -28 -33 -187 -133 -166 -163 -104 -74 -87 -179 -212 -32 -187 -44 -83 -49 7.6 107 -312 115 487 -232 570 529 834 317 1,664
0.9 0.5 2.4 -0.8 0.2 0.9 0.9 0.3 0.5 -0.6 -0.6 1.6 20 55 21 -27 0.2 0.3 -0.1 1.0 3.2 0.9 5.9 40 63 -378 188 237 284 378
-6.8 6.9 3.5 -27 -30 -183 -137 -166 -165 -103 -74 -87 -179 -212 -32 -187 -44 -83 -48 6.5 104 -313 109 447 -296 949 341 598 33 1,287
-2.4 14 30 -2.3 -28 -17 -111 -99 -135 -93 -69 -72 -146 -123 36 -116 32 -15 40 98 205 -253 172 543 -178 630 600 919 408 1,760

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?